PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3039009-0	1987	Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.	Acyclovir	69-78	atypical chemokine receptor 1 (Duffy blood group)	Homo sapiens	42-56	
3039009-4	1987	Therapy with acyclovir delayed and diminished the antibody response to gD, although by day 60 the titers of antibody to gD in acyclovir-treated animals were not significantly different from those in controls.	Acyclovir	13-22	atypical chemokine receptor 1 (Duffy blood group)	Homo sapiens	71-73	
3039009-4	1987	Therapy with acyclovir delayed and diminished the antibody response to gD, although by day 60 the titers of antibody to gD in acyclovir-treated animals were not significantly different from those in controls.	Acyclovir	13-22	atypical chemokine receptor 1 (Duffy blood group)	Homo sapiens	120-122	
3039009-4	1987	Therapy with acyclovir delayed and diminished the antibody response to gD, although by day 60 the titers of antibody to gD in acyclovir-treated animals were not significantly different from those in controls.	Acyclovir	126-135	atypical chemokine receptor 1 (Duffy blood group)	Homo sapiens	120-122	
33390306-11	2021	Combined effects of EGCG and ACV were more evident for the expression of viral thymidine kinase, ICP5 and glycoprotein D.	Acyclovir	29-32	atypical chemokine receptor 1 (Duffy blood group)	Homo sapiens	106-120